• Are you an HIV advocate or peer educator working in a resource-constrained setting?
• Are you interested in HIV cure-related advocacy?
• Would you like to strengthen your understanding of the latest HIV cure research?

IAS – the International AIDS Society – and the AIDS Vaccine Advocacy Coalition (AVAC) are pleased to announce that applications are open for the 2022 Advocacy-for-Cure Academy. The academy is designed for people in countries with limited resources for HIV cure research who are interested in working towards an HIV cure.

The academy will award fellowships to about 20 applicants to participate in a series of interactive workshops with faculty comprised of world-renowned scientists and advocates.The academy will take place in Durban, South Africa, on 16-18 November 2022.

The deadline for applications is 21 August 2022 at 23:59 CET.

The Advocacy-for-Cure Academy will provide the tools and resources for fellows to develop their research literacy in HIV cure and improve and reinforce their advocacy and engagement skills in line with recommendations from Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

The objectives are to:

• Provide training and skills building on current HIV cure research strategies, barriers to a cure, and accurately communicating scientific results, especially to communities.
• Develop translational tools to disseminate information to the wider community, including policy makers, the media and programme managers.
• Create opportunities to interact with leading researchers and advocates in the field to expand the network of advocates working in the HIV cure area.

To be eligible applicants should:

• Have sufficient proficiency in English
• Be an advocate or peer educator in the HIV field
• Be affiliated with HIV associations, groups or committees based in countries with limited resources for HIV cure research
• Be interested in the latest research developments towards an HIV cure

Please contact hivcure@iasociety.org with any questions.